Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 19
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.02%
|
$1,980
$198.48 P/Share
|
|
Jan 19
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
55
+0.11%
|
$10,890
$198.48 P/Share
|
|
Jan 15
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
215,000
-0.06%
|
$40,850,000
$190.31 P/Share
|
|
Jan 13
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.06%
|
$39,060,000
$186.33 P/Share
|
|
Jan 11
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
220,000
-0.05%
|
$40,920,000
$186.24 P/Share
|
|
Dec 21
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.02%
|
$2,016
$168.78 P/Share
|
|
Nov 16
2020
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+2.48%
|
$174,300
$140.59 P/Share
|
|
Nov 16
2020
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+22.83%
|
$174,300
$140.59 P/Share
|
|
Nov 16
2020
|
Katherine Baicker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+5.78%
|
$174,300
$140.59 P/Share
|
|
Nov 16
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,259
+2.07%
|
$176,260
$140.59 P/Share
|
|
Nov 16
2020
|
Carolyn R Bertozzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+16.63%
|
$174,300
$140.59 P/Share
|
|
Nov 16
2020
|
Kathi P Seifert Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+1.59%
|
$174,300
$140.59 P/Share
|
|
Nov 16
2020
|
Michael L Eskew Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+2.77%
|
$174,300
$140.59 P/Share
|
|
Nov 16
2020
|
Marschall S Runge Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+8.02%
|
$174,300
$140.59 P/Share
|
|
Nov 16
2020
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+1.83%
|
$174,300
$140.59 P/Share
|
|
Nov 16
2020
|
Jamere Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+15.13%
|
$174,300
$140.59 P/Share
|
|
Nov 16
2020
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+9.01%
|
$174,300
$140.59 P/Share
|
|
Nov 16
2020
|
William G Kaelin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+6.23%
|
$174,300
$140.59 P/Share
|
|
Oct 19
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.02%
|
$1,988
$142.8 P/Share
|
|
Oct 01
2020
|
Joshua L Smiley |
SELL
Payment of exercise price or tax liability
|
Direct |
3,482
-7.75%
|
$515,336
$148.02 P/Share
|
|
Oct 01
2020
|
Joshua L Smiley |
BUY
Exercise of conversion of derivative security
|
Direct |
7,947
+15.03%
|
-
|
|
Sep 21
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$1,963
$151.18 P/Share
|
|
Sep 08
2020
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
SELL
Open market or private sale
|
Direct |
5,000
-17.49%
|
$755,000
$151.01 P/Share
|
|
Sep 01
2020
|
Michael B Mason EVP & Pres., Lilly Diabetes |
SELL
Payment of exercise price or tax liability
|
Direct |
2,735
-12.85%
|
$404,780
$148.39 P/Share
|
|
Sep 01
2020
|
Michael B Mason EVP & Pres., Lilly Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct |
6,244
+22.69%
|
-
|
|
Aug 17
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$1,963
$151.53 P/Share
|
|
Aug 17
2020
|
Stephen F Fry SVP, HR & Diversity |
SELL
Open market or private sale
|
Direct |
7,204
-6.71%
|
$1,080,600
$150.64 P/Share
|
|
Jul 20
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.02%
|
$2,004
$167.04 P/Share
|
|
Jul 09
2020
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct |
11,000
-37.1%
|
$1,870,000
$170.0 P/Share
|
|
Jul 09
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
12,961
-0.01%
|
$2,203,370
$170.0 P/Share
|
|
Jul 07
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.09%
|
$35,070,000
$167.49 P/Share
|
|
Jul 06
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.06%
|
$34,235,000
$167.41 P/Share
|
|
Jul 05
2020
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,114
-20.54%
|
$181,582
$163.87 P/Share
|
|
Jul 05
2020
|
Leigh Ann Pusey EVP, Corp. Affairs & Comm. |
BUY
Exercise of conversion of derivative security
|
Direct |
2,468
+31.27%
|
-
|
|
Jun 30
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
166,832
-0.07%
|
$27,193,616
$163.61 P/Share
|
|
Jun 29
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
11,431
-0.01%
|
$1,863,253
$163.7 P/Share
|
|
Jun 26
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
63,474
-0.03%
|
$10,346,262
$163.01 P/Share
|
|
Jun 18
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
53,770
-0.02%
|
$8,656,970
$161.88 P/Share
|
|
Jun 17
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
161,230
-0.05%
|
$26,119,260
$162.07 P/Share
|
|
Jun 16
2020
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct |
17,000
-20.11%
|
$2,754,000
$162.5 P/Share
|
|
Jun 16
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
212,337
-0.02%
|
$34,398,594
$162.97 P/Share
|
|
Jun 15
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.02%
|
$1,974
$141.52 P/Share
|
|
Jun 05
2020
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct |
10,000
-17.65%
|
$1,500,000
$150.0 P/Share
|
|
May 18
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.02%
|
$1,884
$157.96 P/Share
|
|
Apr 27
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
12,663
-0.01%
|
$2,064,069
$163.6 P/Share
|
|
Apr 24
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
220,000
-0.05%
|
$35,640,000
$162.61 P/Share
|
|
Apr 23
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
230,000
-0.05%
|
$36,800,000
$160.59 P/Share
|
|
Apr 20
2020
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.02%
|
$1,884
$157.79 P/Share
|
|
Apr 14
2020
|
Aarti S. Shah SVP & CIDO |
SELL
Open market or private sale
|
Direct |
2,000
-9.48%
|
$300,000
$150.0 P/Share
|
|
Apr 09
2020
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
230,000
-0.1%
|
$33,350,000
$145.5 P/Share
|